Nautilus Biotechnology, Inc.
Nautilus Biotechnology, Inc. (NAUT) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 46 transactions totaling $60.0M, demonstrating a bullish sentiment with $59.5M in net insider flow. The most recent transaction on Nov 6, 2025 involved a purchase of 4,000 shares valued at $6.0K.
NAUT Insider Activity Summary
Who Is Buying NAUT Stock?
No significant insider buying has been recorded for NAUT in the recent period.
Who Is Selling NAUT Stock?
No significant insider selling has been recorded for NAUT in the recent period.
Is Nautilus Biotechnology, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for NAUT is bullish with an Insider Alignment Score of 100/100 and a net flow of $59.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
NAUT Frequently Asked Questions
Understanding NAUT Insider Activity
Insider trading at Nautilus Biotechnology, Inc. (NAUT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading NAUT stock, having executed 46 transactions in the past 90 days. The most active insider is Life Sciences Master Fund Ltd Perceptive (Executive), who has made 4 transactions totaling $56.1M.
Related Tools
Track Nautilus Biotechnology, Inc. Insider Activity
Get notified when executives and directors at NAUT file new Form 4 transactions